Hiroaki Mita
Impact in
- Cancer Research top 5%
- Molecular Biology top 5%
- Epigenetics and DNA Methylation
- Cancer-related gene regulation
- RNA modifications and cancer
- Ubiquitin and proteasome pathways
- Wnt/β-catenin signaling in development and cancer
- DNA Repair Mechanisms
Papers in
-
- Epigenetics and DNA Methylation 10
- RNA modifications and cancer 5
- Ubiquitin and proteasome pathways 4
- Surgery 15
- Helicobacter pylori-related gastroenterology studies 3
- Gastrointestinal disorders and treatments 3
- Co-authors
- Takashi Tokino (25 shared papers)Yasushi Sasaki (26 shared papers)Hiromu Suzuki (21 shared papers)Kohzoh Imai (23 shared papers)Minoru Toyota (21 shared papers)Kimishige Akino (15 shared papers)Yasuhisa Shinomura (14 shared papers)Ayumi Satoh (8 shared papers)
- Journals
- Clinical Cancer Research (4 papers)Oncogene (3 papers)Tumor Biology (3 papers)British Journal of Cancer (2 papers)Journal of Biological Chemistry (2 papers)
- Partner nations
- JapanUnited StatesRussia
In The Last Decade
Hiroaki Mita
50 papers receiving 2.0k citations
Peers
Comparison fields: 5 of 95
- Cancer Research 278
- Molecular Biology 1.4k
- Oncology 426
- Cell Biology 179
- Pathology and Forensic Medicine 178
Countries citing papers authored by Hiroaki Mita
This map shows the geographic impact of Hiroaki Mita's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Hiroaki Mita with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Hiroaki Mita more than expected).
Fields of papers citing papers by Hiroaki Mita
This network shows the impact of papers produced by Hiroaki Mita. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Hiroaki Mita. The network helps show where Hiroaki Mita may publish in the future.
Co-authors
The 25 scholars most cited alongside Hiroaki Mita, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 52 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2007 | 198 | |
| 2 | 2003 | 167 | |
| 3 | 2002 | 137 | |
| 4 | Epigenetic inactivation of CHFR and sensitivity to microtubule inhibitors in gastric cancer. | 2003 | 134 |
| 5 | 2005 | 133 | |
| 6 | 2005 | 113 | |
| 7 | 2004 | 93 | |
| 8 | 2006 | 86 | |
| 9 | 2012 | 86 | |
| 10 | 2005 | 86 | |
| 11 | 2004 | 82 | |
| 12 | 2006 | 64 | |
| 13 | Identification of HRK as a target of epigenetic inactivation in colorectal and gastric cancer. | 2003 | 59 |
| 14 | 2004 | 56 | |
| 15 | 2009 | 54 | |
| 16 | 2009 | 47 | |
| 17 | 2008 | 46 | |
| 18 | 2004 | 43 | |
| 19 | 2005 | 32 | |
| 20 | Identification of the interleukin 4 receptor alpha gene as a direct target for p73. | 2003 | 31 |
About Hiroaki Mita
Hiroaki Mita is a scholar working on Molecular Biology, Surgery, Oncology, Pulmonary and Respiratory Medicine and Epidemiology, having authored 52 papers that have together received 2.0k indexed citations. Recurring topics across this work include Epigenetics and DNA Methylation (10 papers), Microtubule and mitosis dynamics (5 papers), RNA modifications and cancer (5 papers), Ubiquitin and proteasome pathways (4 papers), Pancreatic and Hepatic Oncology Research (4 papers), Neuroendocrine Tumor Research Advances (4 papers), Helicobacter pylori-related gastroenterology studies (3 papers) and Gastrointestinal disorders and treatments (3 papers). The work is most often cited by research in Cancer Research (278 citations), Molecular Biology (1.4k citations), Oncology (426 citations), Cell Biology (179 citations) and Pathology and Forensic Medicine (178 citations). Hiroaki Mita has collaborated with scholars based in Japan, United States and Russia. Frequent co-authors include Takashi Tokino, Yasushi Sasaki, Hiromu Suzuki, Kohzoh Imai, Minoru Toyota, Kimishige Akino, Yasuhisa Shinomura, Ayumi Satoh, Fumio Itoh and Kazuhiro Ogi. Their work appears in journals such as Clinical Cancer Research, Oncogene, Tumor Biology, British Journal of Cancer and Journal of Biological Chemistry.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.